SHIFT Newsroom · GLOBAL
GLP-1 safety-report study identifies signals, not rates of harm
A study in Diabetes, Obesity and Metabolism combined spontaneous adverse-event reports with regulatory and medicine-use information.
A study in Diabetes, Obesity and Metabolism combined spontaneous adverse-event reports with regulatory and medicine-use information. It identified areas for safety surveillance, including gastrointestinal problems and medication-use errors. The authors explicitly state that these data do not estimate incidence, prove causation or compare population-level risk between medicines. Counts of reports must not be read as the chance of a side effect for a patient.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.